Dachaigh › Siondròman Myelodysplastic › New York
Sgrùdaidhean clionaigeach Siondròman Myelodysplastic ann an New York
Tha 38 sgrùdaidhean airson Siondròman Myelodysplastic a’ lorg phàirtichean aig làraichean ann an New York.
Bailtean ann an New York
- New York City21 sgrùdaidhean
- The Bronx9 sgrùdaidhean
- Buffalo8 sgrùdaidhean
- Rochester6 sgrùdaidhean
- Queens6 sgrùdaidhean
- Greenburgh5 sgrùdaidhean
- New Rochelle3 sgrùdaidhean
- Staten Island3 sgrùdaidhean
Teacsa sgrùdaidh oifigeil (Beurla)
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
- Roswell Park Cancer Institute, Buffalo
- Stony Brook University Medical Center, Stony Brook
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06577441Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- agus 1 a bharrachd
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06484062A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1
Aoisean 12 gu 78 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT03802695MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Commack, Commack
- Northwell Health/Center for Advanced Medicine, Lake Success
- agus 9 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05564390Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT05320198A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Hematology Oncology Associates of Rockland, Nyack
- Albert Einstein College - Montefiore, The Bronx
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT07422480Collection of Tissue Samples for Cancer Research
- Roswell Park Cancer Institute, Buffalo
A’ fastadhSgrùdadh amharc
2 Months · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT00900198A Telehealth Advance Care Planning Intervention
- University of Rochester, Rochester
A’ fastadh
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT05875805Cord Blood Transplant in Adults With Blood Cancers
- Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 2
Aoisean 21 gu 65 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT05884333Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
- MSKCC, New York
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06465953The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- NYU Langone Hospital - Long Island, Mineola
- agus 7 a bharrachd
A’ fastadhÌre 1/2
Suas gu aois 22 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04726241A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Northwell Health, Lake Success
- Clinical Research Alliance NY, Westbury
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT06499285A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
- New York Cancer and Blood, Shirley
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT04419649ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
- NYU Langone Health, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06656494Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
- Ichan School of Medicine at Mount Sinai, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT05308264Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Research Site, New York
A’ fastadhÌre 1/2
Aoisean 16 agus nas sine · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT07155226Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
- Albany Medical Center, Albany
A’ fastadhSgrùdadh amharc
Suas gu aois 30 · Gach gnè · Air ùrachadh 16 Iuch 2026 · NCT04968834Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07216443Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
- Wilmot Cancer Institute, University of Rochester, Rochester
A’ fastadhÌre 1 tràth
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT03964506Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A’ fastadhÌre 2
Suas gu aois 26 · Gach gnè · Air ùrachadh 14 Cèit 2026 · NCT07566377A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Roswell Park Comprehensive Cancer Center, Buffalo
- New York University Langone Hospital - Long Island, Mineola
- Perlmutter Cancer Center - 34th Street, New York
- agus 2 a bharrachd
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Gibl 2026 · NCT04256317A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
- Icahn School of Medicine at Mount Sinai, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT06146257A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
- The University of Rochester, Rochester
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT05732103Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
- Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Màrt 2026 · NCT07107126A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Roswell Park Comprehensive Cancer Center, Buffalo
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 24 Màrt 2026 · NCT04988555FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia
- Montefiore Medical Center, The Bronx
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Màrt 2026 · NCT07283094CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- Roswell Park Cancer Institute, Buffalo
- New York University, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Faoi 2026 · NCT05143996Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
- Montefiore Einstein Cancer Center and Children's Hospital at Montefiore (CHAM), The Bronx
A’ fastadhÌre 1
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Faoi 2026 · NCT05342584Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- Montefiore Medical Center, The Bronx
- White Plains Hospital, White Plains
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Faoi 2026 · NCT05184842Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- Montefiore Medical Center, The Bronx
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Dùbh 2025 · NCT04245397Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML
- Montefiore Medical Center, The Bronx
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Samh 2025 · NCT05986240SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- agus 2 a bharrachd
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774Umbilical Cord Blood Transplantation From Unrelated Donors
- Wilmot Cancer Institute, Rochester
A’ fastadhSgrùdadh amharc
2 Months – 75 Years · Gach gnè · Air ùrachadh 10 Dàmh 2025 · NCT03016806A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2025 · NCT06501196Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
- University of Rochester Medical Center, Rochester
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2025 · NCT01311258Study of REM-422 in Patients With AML or Higher Risk MDS
- Memorial Sloan Kettering, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Gibl 2025 · NCT06297941Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Gibl 2025 · NCT06462365A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Memorial Sloan-Kettering Cancer Center, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Màrt 2024 · NCT04243785Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.